TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 EUR)
| Closing information | 2023/06 (consolidated) | 2021/12 | 2020/12 |
| Turnover |
3,082
|
2,765
|
3,686 |
| Financial expenses |
18
|
0
|
0 |
| Earnings before taxes |
29
|
394
|
611 |
| EBITDA |
200
|
420
|
671 |
| Total assets |
1,937
|
3,189
|
4,074 |
| Current assets |
1,278
|
2,818
|
2,863 |
| Current liabilities |
328
|
408
|
396 |
| Equity capital |
1,211
|
2,383
|
3,507 |
| - share capital |
17
|
20
|
21 |
| Employees (average) |
34
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/06 (consolidated) | 2021/12 | 2020/12 |
| Solvency |
62.5%
|
74.7%
|
86.1% |
| Turnover per employee |
91
|
1,382
|
1,843 |
| Profit as a percentage of turnover |
0.9%
|
14.2%
|
16.6% |
| Return on assets (ROA) |
2.4%
|
12.4%
|
15.0% |
| Current ratio |
389.6%
|
690.7%
|
723.0% |
| Return on equity (ROE) |
2.4%
|
16.5%
|
17.4% |
| Change turnover | |||
| Change turnover % |
-24%
|
18% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 (consolidated) | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.